Less Ads, More Data, More Tools Register for FREE

Pin to quick picksScience Group Regulatory News (SAG)

Share Price Information for Science Group (SAG)

Share Price is delayed by 15 minutes
Get Live Data
585.00    0.00 (0.00%)
Bid:
0.00
Ask:
0.00
Spread: 10.00 (1.724%)
Market Cap: £239.51m
SAG Live PriceLast checked at - London Stock Exchange

Intraday Science Group Share Chart

Director Dealing

25 Mar 2025 14:20

RNS Number : 1080C
Science Group PLC
25 March 2025
Β 

Β 

25 March 2025

Β 

Science Group plc

(the "Company" or "Science Group")

Β 

Director Dealing

Β 

Science Group plc (AIM:SAG) announces that it has been notified by Daniel Edwards, Group Managing Director of the Company that on 25 March 2025 he purchased 6,667 ordinary shares of 1p each in the Company at a price of 425 pence per share.

Β 

Following this purchase, Daniel Edwards has an interest in 100,000 ordinary shares in the Company (being approximately 0.22% of the issued share capital excluding treasury shares).

Β 

All other Directors' beneficial interests in the share capital of the Company remain unchanged and as previously announced.Β 

Β 

Β 

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them

Β 

1.

Details of the person discharging managerial responsibilities/person closely associated

a)

Name: Daniel Edwards

2.

Reason for the notification

a)

Position/status: Group Managing Director

b)

Initial notification/Amendment: Initial notification

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name: Science Group plc

b)

LEI: 2138009OJQT79BDB3E93

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument: Ordinary shares of 1p each.

Identification code: GB00B39GTJ17

b)

Nature of the transaction: Purchase of shares

c)

Price(s) and volume(s):

Price(s)

Volume(s)

425p

6,667

d)

Aggregated information:

Β· Aggregated volume: 6,667

Β· Price: Β£28,334.75

e)

Date of the transaction: 2025-03-25

f)

Place of the transaction: AIMX

Β 

Β 

- Ends -

Β 

Β 

For further information:

Science Group plc

Sarah Cole, Company Secretary

Tel: +44 (0) 1223 875 200

Β 

www.sciencegroup.com Β 

Canaccord Genuity Limited (Nominated Adviser and Joint Broker)

Simon Bridges, Andrew Potts

Tel: +44 (0) 20 7523 8000

Liberum Capital Limited (Joint Broker)

Max Jones, John More

Tel: +44 (0) 20 3100 2000

Β 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Β 
END
Β 
Β 
DSHSELFLIEISEFD
Date   Source Headline
3rd May 20237:00 amRNSTransaction in Own Shares
2nd May 20237:00 amRNSTransaction in Own Share & Total Voting Rights
27th Apr 20237:00 amRNSTransaction in Own Shares
26th Apr 20237:00 amRNSTransaction in Own Shares
25th Apr 20237:00 amRNSTransaction in Own Shares
24th Apr 20237:00 amRNSTransaction in Own Shares
21st Apr 20237:00 amRNSTransaction in Own Shares
19th Apr 20237:00 amRNSTransaction in Own Shares
18th Apr 20237:00 amRNSPosting of documents and Notice of AGM
12th Apr 20237:00 amRNSTransaction in Own Shares
6th Apr 20237:00 amRNSTransaction in Own Shares
5th Apr 20237:00 amRNSTransaction in Own Shares
4th Apr 20237:00 amRNSTransaction in Own Shares
3rd Apr 20237:00 amRNSTransaction in Own Shares
31st Mar 20237:00 amRNSTransaction in Own Shares
30th Mar 20237:00 amRNSTransaction in Own Shares
29th Mar 20237:00 amRNSTransaction in Own Shares
21st Mar 20237:00 amRNSAudited Results for Year Ended 31 December 2022
16th Mar 20231:00 pmRNSNotice of Preliminary Results
14th Mar 20234:45 pmRNSHolding(s) in Company
14th Mar 20233:00 pmRNSHolding(s) in Company
13th Mar 20237:00 amRNSStatement re banking arrangements
13th Mar 20237:00 amRNSBanking Arrangements
2nd Mar 20233:06 pmRNSHolding(s) in Company
10th Feb 20231:20 pmRNSHolding(s) in Company
9th Feb 20232:45 pmRNSHolding(s) in Company
3rd Feb 20237:00 amRNSCompletion of Sale of Westek Technology Ltd
31st Jan 202312:25 pmRNSHolding(s) in Company
31st Jan 202311:35 amRNSHolding(s) in Company
26th Jan 202310:05 amRNSScheme Effective
24th Jan 20232:21 pmRNSCourt Sanction of Scheme of Arrangement
9th Jan 20237:00 amRNSRegulatory Clearance & Scheme Timetable Update
15th Dec 20227:00 amRNSPre-Close Trading and Business Update
14th Dec 20223:33 pmRNSResult of Court Meeting & General Meeting
30th Nov 20224:35 pmRNSTotal Voting Rights
30th Nov 20227:00 amRNSExercise of Share Options
24th Nov 20221:13 pmRNSHolding(s) in Company
21st Nov 20227:00 amRNSPublication of Scheme Document
10th Nov 20227:00 amRNSForm 8 (OPD) (TP Group plc)
7th Nov 20227:00 amRNSForm 8 (DD) - TP Group plc
4th Nov 20227:00 amRNSForm 8 (DD) - TP Group plc
3rd Nov 20224:35 pmRNSTreasury shares issued
3rd Nov 20227:00 amRNSForm 8 (DD) - TP Group plc
2nd Nov 202210:44 amRNSForm 8 (DD) - TP Group plc
2nd Nov 20227:00 amRNSForm 8 (DD) - TP Group plc
1st Nov 202210:33 amRNSRule 2.10 - M&G Letter of Intent
1st Nov 20227:00 amRNSForm 8 (DD) - TP Group plc
31st Oct 20225:41 pmRNSTotal Voting Rights
31st Oct 20225:22 pmRNSForm 8 (OPD) - TP Group plc
31st Oct 20227:00 amRNSRecommended Cash Aquisition of TP Group plc

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.